Correlation Between BioCryst Pharmaceuticals and Cyclacel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both BioCryst Pharmaceuticals and Cyclacel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioCryst Pharmaceuticals and Cyclacel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioCryst Pharmaceuticals and Cyclacel Pharmaceuticals, you can compare the effects of market volatilities on BioCryst Pharmaceuticals and Cyclacel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioCryst Pharmaceuticals with a short position of Cyclacel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioCryst Pharmaceuticals and Cyclacel Pharmaceuticals.
Diversification Opportunities for BioCryst Pharmaceuticals and Cyclacel Pharmaceuticals
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between BioCryst and Cyclacel is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding BioCryst Pharmaceuticals and Cyclacel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclacel Pharmaceuticals and BioCryst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioCryst Pharmaceuticals are associated (or correlated) with Cyclacel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclacel Pharmaceuticals has no effect on the direction of BioCryst Pharmaceuticals i.e., BioCryst Pharmaceuticals and Cyclacel Pharmaceuticals go up and down completely randomly.
Pair Corralation between BioCryst Pharmaceuticals and Cyclacel Pharmaceuticals
Given the investment horizon of 90 days BioCryst Pharmaceuticals is expected to generate 0.4 times more return on investment than Cyclacel Pharmaceuticals. However, BioCryst Pharmaceuticals is 2.47 times less risky than Cyclacel Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Cyclacel Pharmaceuticals is currently generating about -0.21 per unit of risk. If you would invest 760.00 in BioCryst Pharmaceuticals on August 30, 2024 and sell it today you would lose (10.00) from holding BioCryst Pharmaceuticals or give up 1.32% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
BioCryst Pharmaceuticals vs. Cyclacel Pharmaceuticals
Performance |
| Timeline |
| BioCryst Pharmaceuticals |
| Cyclacel Pharmaceuticals |
BioCryst Pharmaceuticals and Cyclacel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BioCryst Pharmaceuticals and Cyclacel Pharmaceuticals
The main advantage of trading using opposite BioCryst Pharmaceuticals and Cyclacel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioCryst Pharmaceuticals position performs unexpectedly, Cyclacel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclacel Pharmaceuticals will offset losses from the drop in Cyclacel Pharmaceuticals' long position.| BioCryst Pharmaceuticals vs. TG Therapeutics | BioCryst Pharmaceuticals vs. Axsome Therapeutics | BioCryst Pharmaceuticals vs. Seres Therapeutics | BioCryst Pharmaceuticals vs. Madrigal Pharmaceuticals |
| Cyclacel Pharmaceuticals vs. Eliem Therapeutics | Cyclacel Pharmaceuticals vs. Ikena Oncology | Cyclacel Pharmaceuticals vs. Ovid Therapeutics | Cyclacel Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |